U.S. Food and drug administration approval: Neratinib for the extended adjuvant treatment of early-stage HER2-positive breast cancer
Harpreet Singh, Amanda J. Walker, Laleh Amiri-Kordestani, Joyce Cheng, Shenghui Tang, Pamela Balcazar, Kimberly Barnett-Ringgold, Todd R. Palmby, Xianhua Cao, Nan Zheng, Qi Liu, Jingyu Yu, William F. Pierce, Selena R. Daniels, Rajeshwari Sridhara, Amna Ibrahim, Paul G. Kluetz, Gideon M. Blumenthal, Julia A. Beaver, Richard Pazdur
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'U.S. Food and drug administration approval: Neratinib for the extended adjuvant treatment of early-stage HER2-positive breast cancer'. Together they form a unique fingerprint.